RecruitingPhase 4NCT05675527

PRP for Glenohumeral Osteoarthritis

Outcomes Following Single Injections of Low-dose Platelet-rich Plasma (PRP), High-dose PRP, or Saline in Patients With Glenohumeral OA: a Randomized Controlled Trial


Sponsor

Hospital for Special Surgery, New York

Enrollment

135 participants

Start Date

May 2, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The glenohumeral joint is the third most common large joint to be affected by OA. Conservative treatments include physical activity, corticosteroid injections, and medications. PRP is an emerging treatment that has shown efficacy in different musculoskeletal conditions. The use of PRP for glenohumeral OA has been described sparingly in the literature but has shown efficacy in a couple studies and case reports. However, all of the previous studies investigating PRP for glenohumeral OA have focused on low-dose PRP preparations (\~3X), and none have compared PRP treatment to saline treatment. This study aims to compare outcomes following single injections of low-dose PRP, high-dose PRP, or saline in patients with glenohumeral osteoarthritis.


Eligibility

Min Age: 18 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether injecting platelet-rich plasma (PRP, derived from a patient's own blood) into the shoulder joint helps reduce pain from glenohumeral osteoarthritis (wear-and-tear of the main shoulder joint). It compares outcomes over time to see if PRP provides lasting pain relief. You may be eligible if... - You are between 18 and 100 years old - You have shoulder joint arthritis confirmed on MRI - Your average shoulder pain is at least 5/10 - You have had shoulder pain for at least 3 months that has not improved with physical therapy - You experienced temporary pain relief after a diagnostic shoulder injection - You have access to email You may NOT be eligible if... - You cannot stop taking anti-inflammatory drugs (NSAIDs) for 2 weeks before and 1 month after the injection - You have already had a PRP injection in the shoulder - You had a steroid injection in the past 3 months or hyaluronic acid in the past 6 months - You are involved in workers' compensation or active litigation related to the shoulder - You take Plavix (clopidogrel) - You have uncontrolled diabetes, HIV, vasculitis, or autoimmune disease - You have an acute fracture or major structural deformity of the shoulder - You have uncontrolled cervical (neck) spine disorders Talk to your doctor about your shoulder imaging results, current medications, and prior injections before considering this study.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALLow-dose PRP

Injection

BIOLOGICALHigh-dose PRP

Injection

OTHERSaline

Injection


Locations(1)

Hospital for Special Surgery

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05675527


Related Trials